期刊文献+

大鼠肾脏损伤早期HIF-1α、PPAR-γ的表达及其对肾脏的保护机制 被引量:3

Expressions of HIF-1α and PPAR-γ in renal early trauma and their protective mechanisms on the kidney
原文传递
导出
摘要 目的探讨经体表创伤后肾脏组织中缺氧诱导因子-1α(HIF-1α)、过氧化物酶体增殖物激活受体γ(PPAR-γ)表达的变化,及创伤后肾脏损伤与修复的作用机制。方法采用自由落体生物撞击仪撞击大鼠脊肋区复制创伤动物模型。实验大鼠分为5组,包括非创伤对照组,创伤后1、6、12、24 h组。采用免疫组织化学方法进行HIF-1α、PPAR-γ染色。结果肾脏创伤后1、24 h HIF-1α表达增强,分布于皮质远曲小管、肾盏旁小管、髓质小管;6、12 h表达减弱,局限于肾盏旁小管、髓质外带小管。各组间比较差异有统计学意义(P<0.05)。PPAR-γ1、24 h呈阳性表达,分布于髓质小管上皮细胞;6、12 h呈阴性表达,各组间比较差异有统计学意义(P<0.05)。结论 HIF-1α、PPAR-γ可能参与了肾脏创伤后缺血、缺氧、再生、修复的过程。 Objective To investigate expressions of hypoxia-inducible factor-1α(HIF-1α) and peroxisome proliferator-activated receptor-gamma(PPAR-γ) in traumatic kidneys,and the mechanisms of kidney trauma and repair.Methods Rats were stricken at the skin of the renal zone by a free-fall from 45 cm height to establish the traumatic rat model.Then,rats were randomly divided into 5 groups: the non-traumatic control group,and 1 h,6 h,12 h and 24 h post-trauma groups.Expressions of HIF-1α and PPAR-γwere detected with immunohistochemical staining.Results Positive expression of HIF-1αwas increased in 1 h and 24 h post-trauma groups,located in cortex distal convoluted tubules,tubules near renal calyces and medullary tubules;while it was distinctly decreased in 6h and 12 h post-trauma groups,located in tubules near renal calyces and tubules at the outer zone of renal medulla.There were significant differences in expression of HIF-1αamong all the groups(P0.05).The PPAR-γ expression was positive in tubules of renal medulla in 1 h and 24 h post-trauma groups(P0.05),however,negative in 6 h and 12 h post-trauma groups.Conclusion HIF-1αand PPAR-γ may participate in the secondary hypoxia,ischemia,regeneration and repair procedures after renal injury.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第1期39-41,45,共4页 Journal of Shandong University:Health Sciences
关键词 肾脏 创伤 缺氧诱导因子-1Α 过氧化物酶体增殖物激活受体γ 大鼠 Wistar Kidney Trauma Hypoxia-inducible factor 1α Peroxisome proliferator-activated receptor-gamma Rats wistar
  • 相关文献

参考文献10

  • 1Bianciardi P,Fantacci M,Caretti A,et al.Chronic in vi-vo hypoxia in various organs:hypoxia-inducible factor-1αand apoptosis[J].Biochem Biophys Res Commun,2006,342(3):875-880.
  • 2于如同,高文昌,赵序元,潘昕.腺病毒介导低氧诱导因子-1α基因对创伤性脑损伤后细胞凋亡的影响[J].实用临床医药杂志,2004,8(1):27-29. 被引量:9
  • 3Kazuhiro Ito,Shimada,Kato D,et al.Protective effects of preischemic treatment w ith pioglitazone,a peroxisome proliferator-activated receptor ligand,on lung ischemia-reperfusion injury in rats[J].European Journal of Car-dio-Thoracic Surgery,2004,25(4):530-536.
  • 4Khandoudi N,Delerive P,Berrebi-Bertrand I,et al.Ros-iglitazone,a peroxisome proliferator activated receptor gamma,inhibits the Jun NH2-terminal kinase/Activating protein1pathway and protects the heart from ischemia-reperfusion injury[J].Diabetes,2002,51(5):1507-1514.
  • 5章慧娣,王伟铭,陈楠.PPARγ与肾脏炎症调节研究进展[J].中国中西医结合肾病杂志,2007,8(5):299-301. 被引量:5
  • 6Weissgarten J,Berman S,Efrati S,et al.Apoptosis and proliferation of cultured mesangial cells isolated from kid-neys of rosiglitazone-treated pregnant diabetic rats[J].Nephrology dialysis transplantation,2006,21(5):1198-1204.
  • 7卢颖,周桥,仲芳,郝旭,李聪,王伟铭,陈楠.罗格列酮对脂多糖诱导肾小管上皮细胞趋化因子分泌的影响及可能机制[J].中华肾脏病杂志,2010(12):909-914. 被引量:1
  • 8Sommer M,Wolf G.Rosiglitazone increases PPAR gam-ma in renal tubular epithelial cells and protects against damage by hydrogen peroxide[J].Am J Nephrol,2007,27(4):425-434.
  • 9Doi S,Masaki T,Arakawa T,et al.Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte grow th factor induction in re-nal ischemia-reperfusion injury[J].Transplantation,2007,84(2):207-213.
  • 10刘静维,修瑞娟.PPAR-γ配体与炎症、心肌缺血/再灌注损伤防治的研究进展[J].中国病理生理杂志,2010,26(1):197-199. 被引量:4

二级参考文献68

  • 1耿登峰,伍卫,金冬梅,雷娟,王景峰.PPARγ激动剂罗格列酮对心肌缺血再灌注损伤的影响[J].中国病理生理杂志,2005,21(5):872-875. 被引量:13
  • 2Guan Y, Zhang Y, Breyer MD. The role of PPARs in the transcriptional control of cellular processes [ J ]. Drug News Perspect, 2002, 15(3) : 147 - 154.
  • 3Bishop - Bailey D. Peroxisome proliferator - activated receptors in the cardiovascular system[ J ]. Br J Pharmacol, 2000, 129(5): 823-834.
  • 4Gurnell M. PPAR gamma and metabolism: insights from the study of human genetic variants [ J ]. Clin Endocrinol ( Oxf), 2003, 59 (3) : 267 - 277.
  • 5Desvergne B, Wahli W. Peroxisome proliferator- activated receptors: nuclear control of metabolism [ J ]. Endocr Rev, 1999, 20(5) : 649 -688.
  • 6Vamecq J, Latruffe N. Medical significance of peroxisome proliferator- activated receptors [ J]. Lancet, 1999, 354 (9173) : 141 - 148.
  • 7Jiang C, Ting AT, Seed B. PPAR -gamma agonists inhibit production of monocyte inflammatory cytokines [ J ]. Nature, 1998, 391(6662) : 82 -86.
  • 8Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator - activated receptor - gamma is a negative regulator of macrophage activation [ J ]. Nature, 1998, 391 (6662) : 79 - 82.
  • 9Colville - Nash PR, Qureshi SS, Willis D, et al. Inhibition of inducible nitric oxide synthase by peroxisome proliferator - activated receptor agonists : correlation with induction of heme oxygenase 1 [ J]. J Immunol, 1998, 161 (2) : 978 - 984.
  • 10Wang TD, Chen WJ, Lin JW, et al. Effects of rosiglitazone on endothelial function, C - reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome [ J]. Am J Cardiol, 2004, 93 (3) : 362 - 365.

共引文献15

同被引文献26

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部